Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -43.88% |
| Q3 2025 | 14.14% |
| Q2 2025 | -13.13% |
| Q1 2025 | 15.55% |
| Q4 2024 | -1.47% |
| Q3 2024 | 7.28% |
| Q2 2024 | -1.01% |
| Q1 2024 | 22.90% |
| Q4 2023 | -53.07% |
| Q3 2023 | -28.70% |
| Q2 2023 | 19.99% |
| Q1 2023 | 7.32% |
| Q4 2022 | 7.89% |
| Q3 2022 | -16.95% |
| Q2 2022 | -3.48% |
| Q1 2022 | 18.67% |
| Q4 2021 | 28.71% |
| Q3 2021 | -34.97% |
| Q2 2021 | -67.03% |
| Q1 2021 | -39.94% |
| Q4 2020 | 40.23% |
| Q3 2020 | -5.98% |
| Q2 2020 | -331.51% |
| Q1 2020 | 5.15% |
| Q4 2019 | 62.55% |
| Q3 2019 | -222.99% |
| Q2 2019 | -61.49% |
| Q1 2019 | 91.44% |
| Q4 2018 | -942.37% |
| Q3 2018 | 74.27% |
| Q2 2018 | -187.97% |
| Q1 2018 | 64.06% |
| Q4 2017 | 70.47% |
| Q3 2017 | -861.47% |
| Q2 2017 | -41.54% |
| Q1 2017 | -102.82% |
| Q4 2016 | -28.78% |
| Q3 2016 | 1257.89% |
| Q2 2016 | 755.67% |
| Q1 2016 | 0.93% |